Background: COVID-increases risk of DKA and poor outcomes in patients with diabetes.

Methods: A retrospective review was conducted of 4,959 DKA admissions from 1/1/2019-12/31/2021 at our hospital system. EHR data was collected on consecutive admissions coded with DKA for clinical characteristics, hospital outcomes of length of stay (LOS) , 30day readmission (30d RADM) and mortality. Data was analyzed for differences stratified by year 20vs. 2020 and 2021, and by COVID-infection.

Results: Compared to 2019, patients in 2020 were older, more Hispanic and had CHF. Compared to 2019, patients in 2021 had less HTN and kidney disease but similar rates of CHF; Table 1. Mortality and LOS were higher for 2020 and 2021 while 30d RADM was lower; Table 2.

Conclusion: Despite advancements in COVID-treatments, DKA patients have progressively poorer outcomes.


A.Kansara: None. D.T.Nguyen: None. S.L.Yarlagadda: None. E.Graviss: None. A.R.Sadhu: Advisory Panel; Abbott Diagnostics.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at